Role of MRI in Diagnosing and Treating Cervical Carcinoma

Diagnostic Capabilities of MRI

MRI provides excellent soft tissue characterization, allowing for more accurate staging assessment than CT or ultrasound, with 86% agreement between MRI and surgical pathologic findings for tumor size and local extent evaluation, as recommended by the American College of Radiology 2, 3
MRI demonstrates high diagnostic performance with pooled sensitivity of 71-88% and specificity of 86-95% for assessing the extent of cervical cancer invasion, according to the American College of Radiology 2, 4
Specifically for parametrial invasion, MRI shows 71% sensitivity and 91% specificity, which is significantly better than CT, as stated by the American College of Radiology 2, 5

The addition of diffusion-weighted imaging (DWI) improves interobserver agreement and increases sensitivity and specificity for parametrial involvement to 82% and 97% respectively, as reported by the American College of Radiology 2, 6
3T MRI scanners provide higher sensitivity (84%) compared to 1.5T scanners (66%) for local extent evaluation, according to the American College of Radiology 2, 6

For smaller tumors (≤4 cm, stages IA2, IB1, IB2, IIA1), radical hysterectomy with lymph node sampling is typically recommended, based on MRI findings, as suggested by the American College of Radiology 7
For fertility preservation, trachelectomy can be considered for stage IA2 or IB1 tumors, with MRI providing critical assessment of tumor proximity to internal os (sensitivity 73%, specificity 98.3%), as reported by the American College of Radiology 2, 6

MRI is valuable for evaluating treatment response, with the suggested time interval being 3-6 months after completion of therapy, as recommended by the American College of Radiology 8, 9
A study at median 9 weeks post-chemoradiation with strict objective diagnostic criteria achieved sensitivity of 91% and specificity of 85% for residual disease, according to the American College of Radiology 8, 9

PET/MRI shows promise as a comprehensive examination modality, combining MRI's excellent local staging capabilities with PET's superior detection of nodal and distant metastases, as reported by the American College of Radiology 3, 4
PET/MRI also offers prognostic information, with higher SUV max associated with poorer prognosis, according to the American College of Radiology 4

MRI relies primarily on size criteria for nodal evaluation, making it less sensitive than FDG-PET/CT for detecting metastases in subcentimeter lymph nodes, as stated by the American College of Radiology 8, 9
Early post-treatment MRI (<2 months) may show high false-positive rates (sensitivity 80%, specificity 55%) due to difficulty distinguishing post-radiation changes from residual tumor, as reported by the American College of Radiology 8, 9